FDA clears Owlet’s medical pulse-oximetry device BabySat

Owlet announces clearance from the U.S. Food and Drug Administration of BabySat ,”the first medical pulse-oximetry device featuring its advanced, wire-free sock design, the company said. Owlet is a leader in infant health data, having monitored more than 1M babies, and with BabySat, combines its consumer-first expertise with hospital-grade monitoring accuracy,” said the company.